Literature DB >> 5896933

The peripheral white blood cells and metronidazole.

Y Lefebvre, H C Hesseltine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5896933

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Neutropenia associated with metronidazole therapy.

Authors:  J A Smith
Journal:  Can Med Assoc J       Date:  1980-08-09       Impact factor: 8.262

Review 2.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

3.  Metronidazole versus anaerobes. In vitro data and initial clinical observations.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Calif Med       Date:  1972-12

4.  Anti-inflammatory Effect of Metronidazole in Hospitalized Patients with Pneumonia due to COVID-19.

Authors:  Muhanna Kazempour; Hossein Izadi; Arezoo Chouhdari; Morteza Rezaeifard
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

5.  Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.

Authors:  M P Law; D G Hirst; J M Brown
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.